EDITORIAL
Published on 11 Mar 2020
Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
doi 10.3389/fphar.2020.00312
- 2,761 views
- 10 citations
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer Diseases and Acute and Chronic Pain
The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer Diseases and Acute and Chronic Pain
12k
Total downloads
68k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
PERSPECTIVE
Published on 31 May 2019
Antitumor Cannabinoid Chemotypes: Structural Insights
doi 10.3389/fphar.2019.00621
- 10,288 views
- 29 citations
REVIEW
Published on 09 May 2019
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
doi 10.3389/fphar.2019.00430
- 11,710 views
- 63 citations
ORIGINAL RESEARCH
Published on 16 Apr 2019
Oral Cannabidiol Prevents Allodynia and Neurological Dysfunctions in a Mouse Model of Mild Traumatic Brain Injury
doi 10.3389/fphar.2019.00352
- 11,388 views
- 55 citations
REVIEW
Published on 05 Apr 2019
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
doi 10.3389/fphar.2019.00339
- 27,455 views
- 102 citations
ORIGINAL RESEARCH
Published on 18 Dec 2018
Therapeutic Effect of the Substrate-Selective COX-2 Inhibitor IMMA in the Animal Model of Chronic Constriction Injury
doi 10.3389/fphar.2018.01481
- 2,978 views
- 11 citations
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
Impact
- 68kTopic views
- 54kArticle views
- 12kArticle downloads